Abstract
Introduction: Allergic diseases constitute a growing public health challenge,currently affecting approximately 20% of the world's population, with projections indicating thatthis number could reach 50% by 2030. Allergen-specific immunotherapy is, to date, the only approach capable of modifying the course of the disease. However,conventional allergen extracts have several limitations, such…